Current COVID-19 vaccine studies
The UK is a leading force in the development of vaccines for COVID-19. Search our database of studies and trials currently under way.
Filter by:
Project name
Lead Institution
Summary
Funders
St George's Vaccine Institute
A phase 3 trial to evaluate the efficacy and safety of a recombinant spike protein nanoparticle vaccine in adults.
St George's Vaccine Institute
This trial will compare vaccines that are currently being used for the UK vaccination programme, as well as new vaccines as they are approved, in low-risk pregnant women aged 18-45 years-old and between 13-34 weeks gestation.
University Hospital Southampton NHS Foundation Trust
COV-BOOST aims to find out which vaccines against COVID-19 are most effective as a booster vaccination.
National Institute for Health Research (NIHR), Vaccine Task Force
The University of Oxford
PITCH is a prospective, longitudinal observational cohort study to evaluate the immune response to SARS-CoV-2 infection and vaccination over time in healthcare workers, with a focus on the T cell response.
Department of Health and Social Care
University of Glasgow
The OCTAVE trial is a multi-centre, multi-disease, prospective observational cohort trial to investigate the effectiveness of COVID-19 vaccines in clinically at-risk patient groups.
National Institute for Health Research (NIHR), UK Research and Innovation (UKRI)
University of Oxford
This is a single-blind randomised trial studying combinations of two different vaccines.
The UK Vaccine Task Force and the National Institute for Health Research (NIHR)
Imperial College London
The purpose of this trial is to evaluate whether a new self-amplifying ribonucleic acid (RNA) COVID-19 vaccine candidate is safe and whether it produces immune responses against SARS-CoV-2.
Medical Research Council, via UK Research and Innovation.